TVGN
Income statement / Annual
Last year (2024), Tevogen Bio Holdings Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Tevogen Bio Holdings Inc.'s net income was -$13.73 M.
See Tevogen Bio Holdings Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$403.58 K
|
$0.00
|
$0.00
|
$0.00
|
Gross Profit |
-$403.58 K
|
$0.00
|
$0.00
|
$0.00
|
Gross Profit Ratio |
0
|
0
|
0
|
0
|
Research and Development Expenses |
$31.03 M
|
$4.40 M
|
$5.77 M
|
$2.96 M
|
General & Administrative Expenses |
$22.53 M
|
$2.27 M
|
$953.08 K
|
$1.66 M
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$22.53 M
|
$2.27 M
|
$953.08 K
|
$1.66 M
|
Other Expenses |
-$403.58 K
|
$0.00
|
-$7.38 M
|
$0.00
|
Operating Expenses |
$53.16 M
|
$2.27 M
|
$953.08 K
|
$4.62 M
|
Cost And Expenses |
$53.56 K
|
$8.84 K
|
$953.08 K
|
$4.62 M
|
Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Interest Expense |
$184.04 K
|
$256.03 K
|
$0.00
|
$598.50 K
|
Depreciation & Amortization |
$403.58 K
|
$197.55 K
|
$230.82 K
|
$9.38 K
|
EBITDA |
-$13.14 M |
-$2.27 M |
-$953.08 K |
-$28.75 K |
EBITDA Ratio |
0
|
0
|
0
|
0
|
Operating Income Ratio |
0
|
0
|
0
|
0
|
Total Other Income/Expenses Net |
$0.00
|
-$51.63 K
|
$4.42 M
|
-$15.59 M
|
Income Before Tax |
-$13.73 K
|
-$67.33 K
|
$4.41 M
|
-$15.60 M
|
Income Before Tax Ratio |
0
|
0
|
0
|
0
|
Income Tax Expense |
$0.00
|
$0.00
|
-$230.82 K
|
-$9.78 M
|
Net Income |
-$13.73 M
|
-$67.33 K
|
$4.41 M
|
-$15.60 M
|
Net Income Ratio |
0
|
0
|
0
|
0
|
EPS |
-0.0936 |
-0.0004 |
0.0367 |
-0.33 |
EPS Diluted |
-0.0936 |
-0.0004 |
0.0367 |
-0.33 |
Weighted Average Shares Out |
$146.67 M
|
$165.42 M
|
$120.00 M
|
$47.93 M
|
Weighted Average Shares Out Diluted |
$146.67 M
|
$165.42 M
|
$120.00 M
|
$47.93 M
|
Link |
|
|
|
|